Indian Pharma industry, which is facing
tough competition from China in terms of cheaper Active Pharma Ingredients
(APIs), will now concentrate on generic finished product exports to that
country, according to Pharmaceuticals Export Promotion Council (Pharmexcil),
under the Ministry of Commerce & Industry.
The government has constituted a sub-committee, under the chairmanship of joint secretary to look into the product registration in China, present status and hurdles. China is being taken up as a challenge, a senior official said.
This year, it is expected to grow at 20 per cent growth, despite Rupee depreciation against US Dollar. Meanwhile, Bio-Asia 2012 will be held in Hyderabad from February 9-11. BioAsia 2012 will focus on the four key areas of the host country's strengths- Vaccines, Contract Research, Investments and Intellectual Property Rights.
The government has constituted a sub-committee, under the chairmanship of joint secretary to look into the product registration in China, present status and hurdles. China is being taken up as a challenge, a senior official said.
This year, it is expected to grow at 20 per cent growth, despite Rupee depreciation against US Dollar. Meanwhile, Bio-Asia 2012 will be held in Hyderabad from February 9-11. BioAsia 2012 will focus on the four key areas of the host country's strengths- Vaccines, Contract Research, Investments and Intellectual Property Rights.
No comments:
Post a Comment